05-JUL-2022 6:10

GU ACCRUAL REPORT - Open and Recently Closed Studies

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1802-Pros, Stg IV, SST +/- Surg/RT to Primary Tum 1 Y 0 Induction SST 1273 565 174 68 24 6 1 09/24/2018 336 135
            565 174 68 24 6 1      
 
    2 Y 1 Standard Systemic Therapy Only   199 70 29 10 2 1 09/24/2018    
        2 SST + Surgery/RT   205 73 31 12 6 1      
            404 143 60 22 8 2      
 
  S1806-Blad, MIBC, ChemoRT +/- Atezolizumab 1 Y 0 Initial Registration 475 314 125 60 30 11 2 06/03/2019 359 136
            314 125 60 30 11 2      
 
    2 Y 1 Chemo + RT   146 58 32 13 6 1 06/03/2019    
        2 Chemo + RT + Atezolizumab   148 63 28 17 4 0      
            294 121 60 30 10 1      
 
  S1931-RENAL, Stg IV, IO + Nephrectomy. vs IO Only 1 Y 0 Pre-Rand. SST 332 57 47 27 11 3 0 03/08/2021 146 71
            57 47 27 11 3 0      
 
    2 Y 1 Systemic Immuno. Only   18 16 9 5 1 0 03/08/2021    
        2 Nephrectomy + Systemic Immuno.   15 13 7 3 2 0      
            33 29 16 8 3 0      
 
  S1937-Blad, Mets, Eribulin +/- Gem vs SOC 1 Y 1 Physician Choice Chemo 465 4 4 3 2 0 0 06/28/2021 130 49
        2 Eribulin   4 3 2 1 0 0      
        3 Eribulin + Gemcitabine   2 2 1 1 0 0      
            10 9 6 4 0 0      
 
Yes A031102-GCT, Recur, Std Chemo(TIP) vs HD Chemo(TI-CE) 1 E Total Registrations   12 4 1 0 0 0 11/23/2016 74 47
            12 4 1 0 0 0      
 
  A031702-GU, Mets, Cabozantinib+Nivo+Ipi (ICONIC) 1 E Total Registrations   23 5 3 1 0 0 08/09/2019 224 95
            23 5 3 1 0 0      
 
  A031704-RCC, Met, Ipi+Nivo followed by Nivo+/-Cabo 1 E Total Registrations   90 27 12 5 1 0 10/02/2019 250 121
            90 27 12 5 1 0      
 
    2 E Total Registrations   61 24 16 7 2 0 10/02/2019    
            61 24 16 7 2 0      
 
  A031803-Blad, NMIBC, Gemcitabine + MK-3475 1 E Total Registrations   24 11 7 3 0 0 03/18/2020 115 56
            24 11 7 3 0 0      
 
  EA8171-PROS, newly diagnosed, mpMRI for pre-op stagi 1 E Total Registrations   70 24 11 2 1 0 02/11/2019 91 43
            70 24 11 2 1 0      
 
  NRGGU002-Pros, RT + ADT After RP +/- Adj Docetaxel 1 E Total Registrations   4 0 0 0 0 0 08/24/2017 197 80
            4 0 0 0 0 0      
 
    2 E Total Registrations   4 0 0 0 0 0 08/24/2017    
            4 0 0 0 0 0      
 
  NRGGU005-PROS, intmd risk, IGRT& SBRT vs IGRT& HF-IMRT 1 E Total Registrations   9 3 0 0 0 0 03/19/2019 297 123
            9 3 0 0 0 0      
 
No A031701-Bladder, ddGC for MIBC with DDR Tumor Alt 1 E Total Registrations   10 2 2 1 0 0 12/17/2018 144 51
            10 2 2 1 0 0      
 
    2 E Total Registrations   9 2 1 1 0 0 12/17/2018    
            9 2 1 1 0 0      
 
    3 E Total Registrations   1 1 0 0 0 0 12/17/2018    
            1 1 0 0 0 0      
 
  A031801-GU, mRCC, Cabozantinib +/- Radium-223 1 E Total Registrations   6 4 2 0 0 0 11/06/2020 97 37
            6 4 2 0 0 0      
 
  A031901-Blad, Adv/ Met, Duration of Immune Chkpt Tx 0 E Total Registrations   1 1 1 0 0 0 03/18/2022    
            1 1 1 0 0 0      
 
  A031902-Pros, Adv, Enzalutamide + Rucaparib 0 E Total Registrations   4 4 1 0 0 0 10/05/2021 177 75
            4 4 1 0 0 0      
 
    1 E Total Registrations   4 4 1 0 0 0 10/05/2021    
            4 4 1 0 0 0      
 
  EA8134-Penile, Local Adv, ILND +/- Chemo or ChemoRT 1 E Total Registrations   8 1 0 0 0 0 04/25/2019 3 6
            8 1 0 0 0 0      
 
  EA8183-Pros, Dbl Blind Andro Dep + Daro vs Placebo 0 E Total Registrations   7 6 3 1 0 0 01/27/2021 145 59
            7 6 3 1 0 0      
 
    1 E Total Registrations   3 2 0 0 0 0 01/27/2021    
            3 2 0 0 0 0      
 
  EA8191-Pros, Local vs Systemic Thrpy 0 E Total Registrations   1 1 0 0 0 0 09/24/2021 158 60
            1 1 0 0 0 0      
 
    1 E Total Registrations   1 1 0 0 0 0 09/24/2021    
            1 1 0 0 0 0      
 
  EA8192-Blad, High Grade UTUC, Durv + Chemo 1 E Total Registrations   1 1 1 0 0 0 02/23/2022 1 2
            1 1 1 0 0 0      
 
  NRGGU009-Pros, PREDICT-RT 1 E Total Registrations   4 4 4 3 2 0 03/01/2022 302 112
            4 4 4 3 2 0      
 
    2 E Total Registrations   3 3 3 2 2 0 03/01/2022    
            3 3 3 2 2 0      
 
  NRGGU010-Pros, Parallel De-Intens & Intens Trials 1 E Total Registrations   3 3 1 0 0 0 01/03/2022 175 70
            3 3 1 0 0 0      
 
    2 E Total Registrations   3 3 3 0 0 0 01/03/2022    
            3 3 3 0 0 0      
 

05-JUL-2022 6:10

GU Open Studies with No Registrations

Study Registration/Phase Open Date # of
ACT.
INSTs
# of
CURR
IRBs
S2011 Blad, MIBC,Gem+Carbo+Avelumab+Srg vs Srg Only 1 Randomization 06-Oct-21 83 27